相关实验视频
爱米比亚症是一种性病.
1Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO, St Louis, MO 63110, USA. sstanley@im.wustl.edu
Lancet (London, England)
|March 28, 2003
概括
麻疹病是一种致命的寄生虫疾病,是由Entamoeba histolytica引起的. 遗传证据显示,Entamoeba dispar是一种独特的共生物种,改变了我们对菌病的理解.
相关概念视频
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
Same author
The effect of acetylsalicylic acid on thrombin generation in healthy volunteers.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same author
Anesthesia Type during Cancer Surgery: Results of the GA-CARES Randomized, Multicenter Trial.
Anesthesiology·2025
Same author
The impact of interval cholecystectomy timing after percutaneous transhepatic cholecystostomy on post-operative adverse outcomes.
Surgical endoscopy·2023
Same author
Differences in the transcriptome signatures of two genetically related Entamoeba histolytica cell lines derived from the same isolate with different pathogenic properties.
BMC genomics·2010
Same author
Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin.
Nature immunology·2009
Same author
Proteomic comparison of Entamoeba histolytica and Entamoeba dispar and the role of E. histolytica alcohol dehydrogenase 3 in virulence.
PLoS neglected tropical diseases·2009
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026